Fig. 6
Immunotherapy of cancer subtypes. (A-E) Immune suppression signatures and immune exclusion signatures were significantly enriched in CS1, while immune function signatures, immunotherapy signatures, and ICGs were significantly enriched in CS2.
Fig. 6 | Scientific Reports
